Search results for "endocrine"

showing 10 items of 2114 documents

Protection of islets in culture by delivery of oxygen binding neuroglobin via protein transduction.

2005

Islet transplantation has become an accepted method to treat type 1 diabetes. To succeed and achieve normal levels of glucose in transplant recipients, the quality of the transplanted islets is of the utmost importance. Lack of oxygen during organ procurement, islet isolation, and subsequent culture triggers apoptosis or necrosis and loss of islet function, causing the yield and quality to diminish. A promising candidate for cytoprotection against oxygen deprivation is neuroglobin (Ngb). Ngb is a recently described member of globin family and is expressed in neurons, retina, and pancreatic islets. To overexpress this protein in the islets and study its ability to protect them, we utilized p…

endocrine systemmedicine.medical_specialtyendocrine system diseasesCell SurvivalIslets of Langerhans TransplantationNeuroglobinNerve Tissue ProteinsCell SeparationBiologyTransduction (genetics)AutomationIslets of LangerhansOxygen ConsumptionInternal medicinemedicineHumansCells CulturedTransplantationgeographygeography.geographical_feature_categoryMicroscopy ConfocalPancreatic isletsBinding proteinIsletFlow CytometryCytoprotectionCell HypoxiaCell biologyGlobinsTransplantationProtein TransportEndocrinologymedicine.anatomical_structureNeuroglobinGene Products tatSurgeryOxygen bindingTransplantation proceedings
researchProduct

Extrapituitary Effects of Corticotropin Releasing Hormone and Thyrotropin Releasing Hormone

1993

Besides their regulation of the pituitary-adrenal and pituitary-thyroidal axis, respectively, the neurohormones CRH and TRH act within the central nervous system to evoke and modulate a number of behavioral and physiological processes. In particular, an increase in the sympathetic nervous system and respiratory activity has been observed. The data communicated in this review article emphasize the role of these neurohormones with regard to the neuroendocrine regulation of the autonomic nervous system, sleep and cognitive performance. Moreover, a possible therapeutic role is suggested by the beneficial effects in patients at risk of hypoventilation-associated disorders.

endocrine systemmedicine.medical_specialtyendocrine system diseasesCorticotropin-Releasing HormoneCentral nervous systemThyrotropin-releasing hormoneCardiovascular Physiological PhenomenaPsychiatry and Mental healthCorticotropin-releasing hormoneNeuropsychology and Physiological PsychologyEndocrinologymedicine.anatomical_structureInternal medicineRespiratory Physiological PhenomenamedicineAnimalsHumansPsychologyNeurohormonesThyrotropin-Releasing Hormonehormones hormone substitutes and hormone antagonistsBiological PsychiatryNeuropsychobiology
researchProduct

Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies.

2015

Cell-based bioassays for functional thyroid stimulating autoantibodies (TSAb) are sensitive diagnostic tools. However, there is no bioassay available that is standardized with international reference material. We aimed to promote the standardization of the test results among laboratories that perform TSAb bioassays and calibrate TSAb levels against the second international standard (IS) 08/204 from the National Institute for Biological Standards and Control (NIBSC).Serum TSAb activity was measured with a FDA-cleared bioassay that utilizes CHO cells expressing a chimeric thyrotropin receptor (TSHR) and a c-AMP response-element-dependent luciferase. The IS was applied for calibration. TSAb re…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismCHO CellsDiagnostic toolsSensitivity and SpecificityThyrotropin receptorEndocrinologyCricetulusInternal medicineCricetinaeMedicineBioassayAnimalsHumansReceptorAutoantibodiesbiologybusiness.industryAutoantibodyReproducibility of ResultsReceptors Thyrotropineye diseasesGraves DiseaseEndocrinologybiology.proteinBiological AssayAntibodybusinessImmunoglobulins Thyroid-StimulatingThyroid : official journal of the American Thyroid Association
researchProduct

Inhibition of TSH/IGF-1 Receptor Crosstalk by Teprotumumab as a Treatment Modality of Thyroid Eye Disease

2021

Abstract Context We previously presented evidence that TSH receptor (TSHR)-stimulating autoantibodies (TSAbs) bind to and activate TSHRs but do not bind to IGF1 receptors (IGF1Rs). Nevertheless, we showed that IGF1Rs were involved in thyroid eye disease (TED) pathogenesis because TSAbs activated crosstalk between TSHR and IGF1R. Teprotumumab, originally generated to inhibit IGF1 binding to IGF1R, was recently approved for the treatment of TED (Tepezza). Objective To investigate the role of TSHR/IGF1R crosstalk in teprotumumab treatment of TED. Design We used orbital fibroblasts from patients with TED (TEDOFs) and measured stimulated hyaluronan (HA) secretion as a measure of orbital fibrobla…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismClinical BiochemistryThyrotropinStimulationContext (language use)Antibodies Monoclonal HumanizedBiochemistryReceptor IGF Type 1EndocrinologyInternal medicinemedicineHumansHyaluronic AcidOnline Only ArticlesReceptorFibroblastInsulin-like growth factor 1 receptorGene knockdownTeprotumumabChemistryBiochemistry (medical)Receptors Thyrotropineye diseasesGraves Ophthalmopathybody regionsCrosstalk (biology)Endocrinologymedicine.anatomical_structuremedicine.drugThe Journal of Clinical Endocrinology & Metabolism
researchProduct

A Novel Long-Term Graves’ Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies

2020

<b><i>Introduction:</i></b> A novel long-term murine model for Graves’ disease (GD) using repeated, long-term immunizations with recombinant adenovirus expressing the extracellular A-subunit of the human thyrotropin receptor (Ad-TSHR) was applied to evaluate the functional anti-TSHR-antibody (TSHR-Ab) profile. <b><i>Methods:</i></b> BALB/c mice received 7 immunizations with either 10<sup>10</sup> plaque-forming units of Ad-TSHR or control Ad-GFP. Naïve (nonimmuized native) mice were also studied. Three 3-weekly immunizations were followed by 4-weekly boosts until the 7th immunization. Blocking (TBAb) and stimulating (TSAb) TSHR-Ab …

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' disease030209 endocrinology & metabolismlaw.inventionThyrotropin receptor03 medical and health sciences0302 clinical medicineAnimal modellawInternal medicinemedicineExtracellularmedicine.diagnostic_testbiologybusiness.industrymedicine.diseaseSerum sampleseye diseasesEndocrinology030220 oncology & carcinogenesisImmunoassaybiology.proteinRecombinant DNAAntibodybusinessResearch ArticleEuropean Thyroid Journal
researchProduct

Personality types in individuals with type 1 and type 2 diabetes

2020

Objective The Type A personality, characterized by impatience, strong career ambition and competitiveness, is associated with greater sensitivity to external stress. Type 1 diabetes (T1D) is an auto-immune disease, which is potentially influenced by stress, unlike type 2 diabetes (T2D). The aim of this study was to assess whether individuals with T1D and T2D exhibited significant differences on the Type A personality scale. We also assessed personality in patients with thyroid auto-immune diseases to validate potential links between auto-immune disease and Type A personality. Design and methods The Bortner questionnaire was used to assess Type A personality in 188 patients with T1D, 430 pa…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismDiseaseType 2 diabeteslcsh:Diseases of the endocrine glands. Clinical endocrinology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicinePersonalitythyroid disease030212 general & internal medicinetype a personalityauto-immunitymedia_commonType 1 diabeteslcsh:RC648-665business.industryResearchThyroid diseaseThyroidnutritional and metabolic diseasesType A and Type B personality theorymedicine.diseasemedicine.anatomical_structurediabetes mellitusbusinessEndocrine Connections
researchProduct

A New Mutation in the Promoter Region of the PAX8 Gene Causes True Congenital Hypothyroidism with Thyroid Hypoplasia in a Girl with Down's Syndrome

2014

Thyroid dysfunction is common in newborn infants with Down's syndrome (DS), but defects causing classic thyroid dysgenesis (TD) with permanent congenital hypothyroidism (CH) have not been described.We studied a girl with DS and CH who had a mutation in the promoter sequence of the PAX8 gene.A female infant was found to have trisomy 21 and CH, with a venous thyrotropin (TSH) of150 mU/L and a free thyroxine (fT4) of 15.1 pmol/L (day 12). Thyroid peroxidase antibodies and thyroglobulin antibodies were elevated. Scintigraphy showed normal uptake, but ultrasound identified a small gland with heterogenous echotexture and cystic changes. Sequence analysis of the PAX8 gene revealed a new heterozygo…

endocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMutantBiologyThyroid dysgenesisPAX8 Transcription FactorEndocrinologyThyroid peroxidaseInternal medicineCongenital HypothyroidismmedicineHumansPaired Box Transcription FactorsPromoter Regions GeneticInfant NewbornInfantPromotermedicine.diseaseCongenital hypothyroidismHEK293 CellsEndocrinologyThyroid Dysgenesisbiology.proteinFemaleThyroglobulinDown SyndromePAX8TrisomyHeLa CellsThyroid
researchProduct

Clinical Relevance of Thyroid-Stimulating Immunoglobulins in Graves' Ophthalmopathy

2011

Purpose Thyroid-stimulating immunoglobulins (TSIs) likely mediate Graves' ophthalmopathy (GO). The clinical relevance of these functional autoantibodies was assessed in GO. Design Cross-sectional trial. Participants A total of 108 untreated patients with GO. Methods Thyroid-stimulating immunoglobulins, assessed with a novel bioassay, bind to the thyrotropin receptor (TSHR) and transmit signals for cyclic adenosine monophosphate (cAMP)-dependent activation of luciferase gene expression. The cAMP/cAMP response element-binding protein/cAMP-regulatory element complex induces luciferase that is quantified after cell lysis. The TSI levels were correlated with activity and severity of GO and compa…

endocrine systemmedicine.medical_specialtyendocrine system diseasesbiologybusiness.industryGraves' diseaseAutoantibodymedicine.diseaseThyrotropin receptorGraves' ophthalmopathyOphthalmologychemistry.chemical_compoundEndocrinologychemistryInternal medicineImmunopathologyImmunologymedicinebiology.proteinThyroid Stimulating ImmunoglobulinCyclic adenosine monophosphateAntibodybusinessOphthalmology
researchProduct

Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study

1998

OBJECTIVE The optimal antithyroid drug regimen for Graves' disease remains a matter of controversy. The European Multicentre Trial Group has investigated the effects of methimazole drug dose on the long-term outcome of Graves' disease. DESIGN Extended follow-up of patients from a prospective multicentre trial, designed to study methimazole dose effects on the outcome of Graves' disease. We have reported previously that the relapse rates did not differ after a medication-free observation period of 12 months; the relapse rates were 37 and 38%, respectively. In this paper, we describe the outcome in these patients after a mean observation period of 4.3 ± 1.3 years and have looked for potential…

endocrine systemmedicine.medical_specialtyendocrine system diseasesbusiness.industryEndocrinology Diabetes and MetabolismAntithyroid agentmedicine.medical_treatmentGraves' diseaseUrinary systemThyroidLevothyroxinemedicine.diseaselaw.inventionClinical trialEndocrinologymedicine.anatomical_structureEndocrinologyRandomized controlled triallawInternal medicineMedicinebusinessProspective cohort studymedicine.drugClinical Endocrinology
researchProduct

Heart in Hyperthyroidism

2019

Hyperthyroidism is a common endocrine disorder that produces important clinical consequences on the cardiovascular system. In overt hyperthyroidism the increase in left ventricular performance is predominantly sustained by an increased preload with enhanced left ventricular diastolic function and reduced systemic vascular resistance. The pattern of cardiovascular abnormalities is similar in subclinical and overt hypothyroidism, suggesting that a lesser degree of thyroid hormone deficiency may also affect the cardiovascular system. Untreated overt and subclinical hypothyroidism can lead to an increased risk of coronary heart disease (CHD), heart failure (HF), and cardiovascular mortality.

endocrine systemmedicine.medical_specialtyendocrine system diseasesbusiness.industryThyroidmedicine.diseasePreloadmedicine.anatomical_structureHeart failureInternal medicineVascular resistanceCardiologyMedicineEndocrine systembusinesshormones hormone substitutes and hormone antagonistsCardiovascular mortalitySubclinical infectionHormone
researchProduct